Danisco gains rights to apple-based ingredients
October 17, 2008
by Jeff Gelski
Danisco gained exclusive rights for certain apple-based ingredients by signing an agreement with Coressence Ltd. The ingredients will be marketed under the brand name Evesse and contain heart-healthy polyphenols. They will offer cardiovascular benefits and show potential in benefits in other health areas.
Danisco expects to begin selling Evesse in 2011. The company will target the dietary supplement market initially and then develop the food and beverage market. The ingredient will be available as a powder and granule. It will have a neutral taste and odor.
"Our health and nutrition strategy is clear, and we are also moving into new areas of business to become the first choice ingredient partner for our customers in health and nutrition," said Fabienne Saadane-Oaks, president of Danisco Bio Actives. "This product is particularly strong in cardiovascular health, which is one of our key strategic health platforms."
Richard Wood, chief executive of Coressence Ltd., based in the United Kingdom, said, "Coressence has been engaged for the last five years in developing the production of high yielding polyphenol extraction from specially selected and protected apple varieties.
"The long-term collaborative agreement with Danisco for Evesse in the food ingredients market is a key part of our program. As a result, we will build on the special patented technology, developed for the first stage of our licensed agreement, and create second- generation technology formats, all of which can be added to food-based products."